Cargando…

Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human

The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the function...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilmot, Helen, Hockley, Jason, Rigsby, Peter, Gray, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357867/
https://www.ncbi.nlm.nih.gov/pubmed/28373973
http://dx.doi.org/10.3389/fmed.2017.00028
_version_ 1782516123405647872
author Wilmot, Helen
Hockley, Jason
Rigsby, Peter
Gray, Elaine
author_facet Wilmot, Helen
Hockley, Jason
Rigsby, Peter
Gray, Elaine
author_sort Wilmot, Helen
collection PubMed
description The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the functional activity value, assignment of an antigen value to the 2(nd) IS would allow harmonization of antigen assay methods and differentiation of patients who have low functional activity but normal antigen FXI levels from patients who have both low functional and antigen FXI levels. The aims of this study were, therefore, to assign FXI functional activity to the 2(nd) IS for FXI, plasma, and to additionally assign a new analyte, FXI antigen, to the same International Standard. The candidate material was prepared from double-spun, virology negative, normal plasma, which was pooled and filled into siliconized glass ampoules and subsequently freeze-dried. Assignment of the functional activity (FXI:C) value in International Units (IUs) was performed by one-stage clotting assay by 29 laboratories, relative to the 1(st) IS. The overall geometric mean (GM) was 0.71 IU/amp with extremely low inter-laboratory variability (expressed as geometric coefficient of variation) of 1.8%. The antigen value assignment was performed by 11 laboratories and was calculated relative to normal plasma pools, as is customary with new coagulation factor analytes. The amount of antigen present in 1 ml of normal plasma was taken to be 1 U. The overall GM for the antigen assays was 0.78 IU/amp with an inter-laboratory variation of 10%. The candidate (National Institute for Biological Standards and Control code, 15/180) was established by the World Health Organization (WHO) Expert Committee on Biological Standardization in 2016 as the WHO 2(nd) IS for blood coagulation FXI, plasma, with a functional activity value (FXI:C) of 0.71 IU/amp and an antigen value (FXI:Ag) of 0.78 IU/amp.
format Online
Article
Text
id pubmed-5357867
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53578672017-04-03 Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human Wilmot, Helen Hockley, Jason Rigsby, Peter Gray, Elaine Front Med (Lausanne) Medicine The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the functional activity value, assignment of an antigen value to the 2(nd) IS would allow harmonization of antigen assay methods and differentiation of patients who have low functional activity but normal antigen FXI levels from patients who have both low functional and antigen FXI levels. The aims of this study were, therefore, to assign FXI functional activity to the 2(nd) IS for FXI, plasma, and to additionally assign a new analyte, FXI antigen, to the same International Standard. The candidate material was prepared from double-spun, virology negative, normal plasma, which was pooled and filled into siliconized glass ampoules and subsequently freeze-dried. Assignment of the functional activity (FXI:C) value in International Units (IUs) was performed by one-stage clotting assay by 29 laboratories, relative to the 1(st) IS. The overall geometric mean (GM) was 0.71 IU/amp with extremely low inter-laboratory variability (expressed as geometric coefficient of variation) of 1.8%. The antigen value assignment was performed by 11 laboratories and was calculated relative to normal plasma pools, as is customary with new coagulation factor analytes. The amount of antigen present in 1 ml of normal plasma was taken to be 1 U. The overall GM for the antigen assays was 0.78 IU/amp with an inter-laboratory variation of 10%. The candidate (National Institute for Biological Standards and Control code, 15/180) was established by the World Health Organization (WHO) Expert Committee on Biological Standardization in 2016 as the WHO 2(nd) IS for blood coagulation FXI, plasma, with a functional activity value (FXI:C) of 0.71 IU/amp and an antigen value (FXI:Ag) of 0.78 IU/amp. Frontiers Media S.A. 2017-03-20 /pmc/articles/PMC5357867/ /pubmed/28373973 http://dx.doi.org/10.3389/fmed.2017.00028 Text en Copyright © 2017 Wilmot, Hockley, Rigsby and Gray. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wilmot, Helen
Hockley, Jason
Rigsby, Peter
Gray, Elaine
Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
title Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
title_full Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
title_fullStr Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
title_full_unstemmed Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
title_short Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
title_sort establishment of the world health organization 2(nd) international standard for factor xi, plasma, human
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357867/
https://www.ncbi.nlm.nih.gov/pubmed/28373973
http://dx.doi.org/10.3389/fmed.2017.00028
work_keys_str_mv AT wilmothelen establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman
AT hockleyjason establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman
AT rigsbypeter establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman
AT grayelaine establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman